Presentations

ISCHEMIA Presentations at National and International Meetings

AHA November 2022

  • ISCHEMIA Extended Follow-Up Interim Report (Presented by Dr. Judith S. Hochman) Link
  • Biomarkers of Adverse Cardiovascular Events in Chronic Coronary Disease: Data from The ISCHEMIA Trial (Presented by Dr. Jonathan Newman) Link
  • Anomalous Coronary Arteries are Associated with Ischemia in the ISCHEMIA Trial (Poster presented by Dr. Vita Jaspan) Link

ESC August 2022

  • ISCHEMIA-CKD EXTEND Follow-Up: Clinical Outcomes at 5 years of Follow-Up EXTEND-CKD (Presented by Dr. Sripal Bangalore)
  • Factors Associated with Early Catheterization in Patients Randomized to the Conservative Strategy in the ISCHEMIA Trial (Presented by Dr. Radoslav Pracon) (Link)

ACC April 2022

  • Health Status in the ISCHEMIA Trial in relation to Index Ischemia Severity on Stress Imaging and Coronary Artery Disease (Poster presented by Dr. Lawrence M. Phillips)
  • Relationship of Health Status to ISCHEMIA and Coronary Anatomy in the ISCHEMIA Trial (Poster presented by Dr. Lawrence M. Phillips) Link

AHA November 2021

  • Association of Serial Health Status Measurements With Clinical Events: Insights From the ISCHEMIA Trial (Poster Presentation by Dr. John Saxon) Link
  • Whole-Heart Atherosclerosis Quantification and Characterization and Risk of Major Adverse Cardiovascular Events: The ISCHEMIA Trial (Live Presentation by Dr. Harmony Reynolds on behalf of Dr. James Min) Link
  • Health Status Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Crating in Stable Coronary Disease: Secondary Analysis of the ISCHEMIA Trial (Poster Presentation by Dr. Chetan Huded) Link
  • Heterogeneity of Benefit on Quality of Life With an Invasive versus Conservative Strategy for Chronic Coronary Disease. Results From the ISCHEMIA Trial (Poster Presentation by Dr. Suzanne Arnold) Link
  • Association of Medical Non-adherence to Health Status Outcomes in the ISCHEMIA Trial (Poster Presentation by Dr. Raul Garcia) Link

ACC May 2021

  • Impact of Completeness of Revascularization on Clinical Outcomes in Patients With Stable Ischemic Heart Disease Treated With an Invasive Versus Conservative Strategy. (Presented by Dr. Gregg W. Stone) (LBCT) Link
  • Dialysis Initiation in Patients with Stable Ischemic Heart Disease and Severe Chronic Kidney Disease in the ISCHEMIA-CKD Trial. (Presented by Dr. Carlo Briguori) (Moderated Poster) Link
  • Association of BMI with Clinical Outcomes in Patients with Coronary Disease and Advanced Chronic Kidney Disease: Insights for the ISCHEMIA-CKD Trial. (Poster presented by Dr. Evgeny Kretov) Link
  • Global Longitudinal Strain at Rest is Not Predictive of Subsequent Inducible Ischemia Among Patients with Non-Obstructive Coronary Artery Disease in the CIAO-ISCHEMIA Study. (Poster Contribution presented by Dr. Esther Davis) Link
  • Management and Outcomes of Patients with Diabetes Mellitus (DM) and Stable Ischemic Heart Disease (SIHD): Pooled Data from the ISCHEMIA and ISCHEMIA-CKD Trials. (Poster presented by Dr. Jonathan Newman) Link
  • Anatomy Versus Ischemia in the ISCHEMIA-CKD Trial: Does Either Predict Outcome? (Poster presented by Dr. Kevin Bainey) Link
  • Myocardial Infarction Rates by Definition, Type, and Treatment in the ISCHEMIA-CKD Trial (Moderated Poster presented by Dr. Bernard Chaitman) Link

AHA November 2020

  • Clinical And Quality Of Life Outcomes With Chronic Total Occlusion In ISCHEMIA: ISCHEMIA CTO Substudy. (Presented by Dr. Sripal Bangalore) (LBCT) Link
  • Causes Of Cardiovascular And Non-cardiovascular Mortality In The ISCHEMIA Trial (Presented by Dr. Mandeep Sidhu) Link

ASN October 2020

  • Optimal medical therapy in the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA)-Chronic Kidney Disease (CKD): A comparison of patients on and not on dialysis at baseline. (Presented by Dr. Roy Matthew) Link

ESC August 2020

  • Initial Invasive versus Conservative Management for Stable Ischemic Heart Disease with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.(Presented by Dr. R.D. Lopes) Link

SCAI May 2020

  • Outcomes with Intermediate Left Main Disease on Coronary CT Angiography in the ISCHEMIA trial. (Presented by S. Bangalore) Link

ACC March 2020

  • Variation in Myocardial Infarction Rates By Type And Definition In the ISCHEMIA Trial. (Presented by B. Chaitman) Link
  • Predictions of Left Main Disease Using Clinical and Stress Test Parameters. (Presented by R. Senior) Link
  • Relationships Of Ischemia Severity And Coronary Artery Disease Extent With Clinical Outcomes In The Ischemia Trial. (Presented by D. Maron) Link
  • Coronary Anatomy, Ischemia and Angina: Associations at Baseline in the ISCHEMIA trial. (Presented by H. Reynolds) Link
  • Sex Differences in Stress Test and CCTA Findings and Symptoms in the Randomized Ischemia Trial. (Presented by H. Reynolds) Link
  • Clinical And Quality Of Life Outcomes With Invasive Versus Conservative Strategy In Patients With Stable Ischemic Heart Disease Across The Spectrum Of Baseline Kidney Function: Insights From The ISCHEMIA And ISCHEMIA-CKD Trials. (Presented by S. Bangalore) Link
  • Natural History Of Symptoms And Stress Echo Findings In Patients With Moderate Or Severe Ischemia And No Obstructive CAD (INOCA): The NHLBI-funded CIAO Ancillary Study To The ISCHEMIA Trial. (Presented by H. Reynolds) Link